Conclusion: Segmental bowel resection for DIE may be associated with a higher incidence of new bowel symptoms (possibly due to abdominal pain, incomplete bowel movements, and/or false alarms), but not with worse constipation or fecal incontinence, compared with surgery without bowel resection.
Bowel endometriosis has been associated with gastrointestinal symptoms, such as diarrhea, constipation, rectal bleeding, proctitis, tenesmus, and colic rectal pain that can be chronic or menstrual-related. Bowel endometriosis also has been associated with noncyclic chronic pelvic pain [5] . Surgical removal of bowel endometriosis, often using a minimally invasive approach, can be offered to treat these symptoms [6] .
Although bowel resection carriers significant risk to the patient, it can be offered to patients with DIE of the bowel who are experiencing severe symptoms. Bowel resection for endometriosis can be done open or with laparoscopic assistance, with similar outcomes [7] . Complications from the procedure can be considerable, including anemia requiring blood transfusion, anastomotic leakage, fistula formation, and bowel perforation or obstruction [8] [9] [10] . Given the significant morbidity associated with bowel resection, the symptomatic benefits need to outweigh the risks of surgery. Several studies with relatively short-term follow up (median ,2 years) have shown that either operative technique can improve symptoms related to bowel endometriosis, with a resulting improved quality of life [7, [9] [10] [11] ; however, after bowel resection, patients may develop new bothersome symptoms related to the surgery, such as an increase in stools per day or, conversely, constipation or urinary retention [11, 12] . Patients need to be informed of both the immediate operative risk and any long-term functional changes that could occur as a result of this procedure. The aim of this study was to evaluate the long-term (minimum 4 years) outcomes of patients who underwent segmental bowel resection due to DIE in comparison to controls. Primary outcomes included long-term bowel symptoms, and secondary outcomes included long-term outcome of endometriosis-related symptoms after bowel resection.
Materials and Methods
This was a matched cohort study involving women who underwent surgical resection of endometriosis between 1993 and 2007 at the Cleveland Clinic. The study protocol was approved by the Cleveland Clinic's Institutional Review Board (IRB 10-899). Procedure and diagnostic codes were used to perform a search for all patients undergoing surgery with a diagnosis of endometriosis between 1993 to 2007 at our institution. A separate electronic search was done to capture patients with endometriosis who underwent bowel resection with a diagnosis of endometriosis during the same time frame. The electronic or paper medical charts of all identified patients were reviewed. Cases were confirmed by reviewing operative and pathology reports. Additional cases that were missed from the initial electronic search were identified through manual review of the charts. Patients who had undergone bowel resection less than 4 years from the date of data collection were excluded. (At least 4 years of follow-up time were required for the study.) Also excluded were any patients who subsequently developed a primary or metastatic pelvic or abdominal malignancy. Potential controls were identified from the chart review and were used for the matching process.
The control group consisted of patients with stage III/IV endometriosis who underwent surgical removal of disease without a bowel resection. These patients had no known endometriosis-related bowel disease and served to evaluate the overall long-term bowel function of patients with severe endometriosis. As with the cases, controls who had undergone surgery less than 4 years from the start of the study were excluded, as were those who subsequently developed a primary or metastatic pelvic or abdominal malignancy. If a patient had undergone more than 1 surgery for endometriosis, the most recent operation was used for matching purposes.
After demographic data were collected, a detailed questionnaire was sent by mail to the identified cases. Patients who did not respond to the initial contact attempt were sent a second questionnaire by mail and were contacted by telephone when this information was available. When the information obtained was incomplete, patients were subsequently contacted by telephone to obtain the missing information. The questionnaire elicited general information regarding indications for the initial surgery and whether additional medical and surgical treatment had been required since the bowel resection. Cases were then asked to rate the severity of symptoms related to endometriosis, such as dysmenorrhea and chronic pelvic pain, both before their surgery and currently. Finally, the survey contained validated and reliable questionnaires pertaining to current bowel function.
Three separate validated questionnaires were incorporated into the patient survey: the Bristol Stool Form Scale, the St. Mark's Vaizey Fecal Incontinence Grading System, and the Patient Assessment of Constipation Symptoms Questionnaire (PAC-SYM). The Bristol Stool Form Scale is a 7-point descriptive visual scale used to assess a patient's most common stool consistency. The patient selects his or her most common stool consistency based on images and text descriptions of the different stool forms, ranging from a separate hard lump to entirely liquid stool. The Bristol Scale Stool Form is a reliable assessment of stool consistency and has been found to correlate with complete gut transit time [13] . The St. Mark's Vaizey Fecal Incontinence Grading System is a standardized scoring system for assessing the severity of fecal incontinence. The questionnaire enquires about the frequency of incontinence of gas, liquid stool, and solid stool. It also assesses the frequency of urge, the use of pads or plugs, and the use of constipating medications to prevent incontinence. The responses are graded to provide an overall severity of fecal incontinence symptoms that have been found to be reproducible and sensitive to changes produced by treatments [14] . The third validated questionnaire included in the patient survey, the PAC-SYM, is designed to assess the severity of constipation. The patient answers 12 questions pertaining to constipation, including assessing for symptoms of incomplete emptying, small bowel movements, hard bowel movements, straining, false alarms, and rectal bleeding. The PAC-SYM has found to be a highly reliable and valid tool for assessing constipation symptoms in adults [15] . Permission to use the PAC-SYM questionnaire in our survey was granted by the Janssen Research Foundation.
Once the surveys were returned by the case patients, matching was performed to identify adequate control patients. A logistic regression model was fit to the data using age and year of surgery as the independent variables and X as the dependent variable. Propensity scores were calculated from the model. Matching was performed using the R package ''matching'' under several different conditions; the caliper for matching was varied from 0.5 to 1.5 in increments of 0.25. Matching was done by ratios of 1-to-1, 2-to-1, 3-to-1, and 4-to-1, and subjects were matched without replacement. Each of these matched datasets was evaluated using Rubin's rules. Based on these evaluations, the 2-to-1 matching with a caliper of 1 provided the best match; however, because we could not guarantee that all subjects would respond to the survey, we performed 3-to-1 matching (Fig) .
Once the control group surveys were returned, comparisons were performed using the Wilcoxon rank-sum test and the c 2 test. In cases of small frequencies, comparisons were made using the Fisher exact tests. Results were considered statistically significant at a p value % .05. Univariate and multivariate analyses were conducted using R version 3 (R Project for Statistical Computing, Vienna, Austria). A linear mixed-effects model with matched groups serving as a random effect was applied for the multivariate analysis.
Results
The study population comprised 71 patients, including 36 cases and 35 controls. The overall response rate to the surveys was 43% (64% for cases and 32% for controls). The median duration of follow-up was 10.1 years (range, 4-18 years) for the cases and 10.2 years (range, 4-18 years) for the controls. The mean patient age and body mass index (Table 4) ; however, the median total PAC-SYM score was similar in the 2 groups when a linear mixed-effects model with matched groups serving as a random effect was applied ( Table 5) (Table 6 ). Correspondingly, there were no differences in the individual symptoms reported on the Vaizey questionnaire and after application of the linear mixed-effects model (Table 5 ).
Discussion
Our findings in this study suggest that undergoing segmental bowel resection for DIE may be associated with a higher incidence of new bowel symptoms (possibly due to abdominal pain, incomplete bowel movements, and/ or false alarms), but not with worse constipation or fecal incontinence compared with surgery without bowel resection. The treatment for severe endometriosis, particularly in patients with DIE involving the bowel, is often complex and may require a multidisciplinary surgical approach for symptomatic patients who do not improve with medical treatment [16] [17] [18] . Several case series involving segmental bowel resection for DIE have been reported in the literature, but these have been limited owing to a lack of validated questionnaires, small sample size, or absence of a control group that did not undergo bowel surgery [10, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . Moreover, some studies have lacked longterm follow-up [23, 28] . The purpose of the present study was to compare the long-term outcomes of patients who underwent bowel resection for DIE and matched patients with severe endometriosis using validated conditionspecific questionnaires.
The present study suggests that most patients who underwent surgical treatment for endometriosis (with [cases] or without [controls] bowel resection) experienced improvement in dysmenorrhea, chronic nonmenstrual pain, pain with bowel movements, and lower back pain. This improvement in symptoms was not statistically significantly different between the cases and the controls, however. In contrast, a larger proportion of cases than controls experienced reduced rectal bleeding after surgery. When patients were specifically asked about worsened constipation, a larger proportion of cases than controls reported this finding; however, assessment of these symptoms using a valid and reliable questionnaire (PAC-SYM) revealed no significant differences between the 2 groups. In addition, the cases and controls reported a similar proportion of normal stools as evaluated by the Bristol Stool Form Scale, indicating similar stool consistency and transit times. With respect to stool incontinence (Vaizey Fecal Incontinence Grading System), patients who underwent bowel resection did not report a higher incidence of fecal incontinence compared with controls. Regarding patient satisfaction, a similar proportion of cases and controls reported that they would undergo the same surgery again. Nevertheless, the cases were more likely than the controls to report new bowel symptoms. Presumably, these symptoms were abdominal pain, incomplete bowel movements, and false alarms, which were statistically more frequent in the cases (Table 4) . Before undergoing bowel resection, patients should be counseled about the risk of developing these new symptoms after surgery.
Limitations of the present study include the potential for selection or recall bias owing to the study's retrospective and single-institution design, relatively small sample size, and low response rate to the surveys. The small sample size was due to the strict inclusion criteria, that required at least a 4-year follow-up. Nonetheless, it is possible that this study was underpowered to detect smaller, clinically significant differences, or that these symptoms diminished over time after surgery. Moreover, other surgical modalities for treating DIE involving the bowel, such as shaving or discoid resection of lesions, were not performed and thus are not included in our analysis.
The low overall response rate to the surveys (43%) occurred despite systematic attempts to contact both cases and controls. An important contributing factor was the inability to contact many patients at the available address or a forwarding address, given the study's long time span (14 years).
Despite these limitations, however, this study represents an important addition to the literature given the distinctive strengths of long-term follow-up (median follow-up .10 years), use validated questionnaires, and inclusion of matched controls.
Future studies to evaluate the role of bowel surgery for DIE should consider including pain scores as well as overall quality of life markers in addition to validated bowel function questionnaires.
In conclusion, segmental bowel resection for DIE appears to be associated with a higher incidence of new bowel symptoms compared with surgery for advanced endometriosis without bowel resection (possibly owing to abdominal pain, incomplete bowel movements, and/or false alarms). The incidence of constipation or fecal incontinence is similar in these 2 groups of patients, however. 
